Ceryvyn Therapeutics LimitedASX: CYV

Ceryvyn Therapeutics: Results of AGM

· Issued by Ceryvyn Therapeutics Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Ceryvyn Therapeutics Limited has announced the results of its Annual General Meeting, where all resolutions were carried by the requisite majority. The announcement complies with Listing Rule requirements and includes details of the resolutions voted on by shareholders. Ceryvyn is focused on developing therapies for serious diseases, particularly lymphangioleiomyomatosis, with its lead program targeting key proteins involved in disease progression.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

A S X A N N O U N C E M E N T Results of Annual General Meeting Wednesday, 18 November 2026 Ceryvyn Therapeutics Limited (ASX:CYV) (“Ceryvyn” or the “Company”) advises that in accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), the results of the...

Ceryvyn Therapeutics Limited on 6ix

In the deck

Story so far

Earlier from Ceryvyn Therapeutics

Later from Ceryvyn Therapeutics

All Ceryvyn Therapeutics news releases